Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: First Quarter ended March 31, 2023
Filing Date: May 22, 2023
This filing incorporates by reference a press release detailing the Company's first quarter 2023 financial and operational results. The document serves to update investors on recent performance and incorporates specific sections into the Company's active registration statements.
Key Financial Metrics
The provided text is a cover sheet for Form 6-K and does not contain specific numerical data. It references a press release (Exhibit 99.1) for detailed figures.
- Revenue: Not provided in this text.
- Profit/Loss: Not provided in this text.
- Cash Flow: Not provided in this text.
- Margins: Not provided in this text.
- Debt and Liquidity: Not provided in this text.
Material Changes
The filing text does not provide specific comparative data or material changes versus the prior period. It indicates that such information is contained within the incorporated press release titled "Icecure Medical Reports First Quarter 2023 Financial & Operational Results."
Guidance, Outlook, and Risks
The filing incorporates the "Forward Looking Statements" section from the referenced press release. No specific guidance, outlook, risks, or contingencies are detailed in the text of this Form 6-K cover sheet.
Investor Verification Checklist
- Review Exhibit 99.1 (the press release) for actual Q1 2023 revenue, net loss, and cash position figures.
- Verify the specific operational highlights mentioned in the press release regarding product development or commercialization.
- Examine the "Forward Looking Statements" in the press release for updated guidance or risk factors.
- Confirm the impact of these results on the Company's active Form F-3 and Form S-8 registration statements.